alfuzosin has been researched along with Asymmetric Septal Hypertrophy, Familial in 1 studies
alfuzosin: structure given in first source
Excerpt | Relevance | Reference |
---|---|---|
" Incidents of adverse cardiac drug reactions are more common in patients with preexisting heart disease than the general population." | 1.39 | Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity. ( Bers, DM; Diecke, S; Gong, T; Knowles, JW; Lan, F; Lee, AS; Liang, P; Nguyen, PK; Robbins, RC; Sallam, K; Sanchez-Freire, V; Wang, PJ; Wang, Y; Wu, JC, 2013) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Liang, P | 1 |
Lan, F | 1 |
Lee, AS | 1 |
Gong, T | 1 |
Sanchez-Freire, V | 1 |
Wang, Y | 1 |
Diecke, S | 1 |
Sallam, K | 1 |
Knowles, JW | 1 |
Wang, PJ | 1 |
Nguyen, PK | 1 |
Bers, DM | 1 |
Robbins, RC | 1 |
Wu, JC | 1 |
1 other study available for alfuzosin and Asymmetric Septal Hypertrophy, Familial
Article | Year |
---|---|
Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity.
Topics: Action Potentials; Cardiomyopathy, Dilated; Cardiomyopathy, Hypertrophic, Familial; Cell Differentia | 2013 |